History of the World Allergy Organization: Innovation in Continuity 2008–2009

por Canonica, Giorgio Walter
Publicado 2011

Impact of rhinitis on airway inflammation: biological and therapeutic implications

por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado 2001

Local Nasal Specific Immunotherapy for Allergic Rhinitis

por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado 2006

Is Sublingual Immunotherapy the Final Answer? Implications for the Allergist

por Canonica, Giorgio Walter, Passalacqua, Giovanni
Publicado 2008

AIT (allergen immunotherapy): a model for the “precision medicine”

por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado en Clin Mol Allergy (2015)

409 Oral Allergy Syndrome and United Airways Disease: Is There a Functional Connection?

por Lombardi, Carlo, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado 2012

Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper

por Passalacqua, Giovanni, Compalati, Enrico, Canonica, Giorgio Walter
Publicado 2010

European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars

por Agostini, Carlo, Canonica, Giorgio Walter, Maggi, Enrico
Publicado en Clin Mol Allergy (2015)

The WEB-based Asthma Control: an intriguing connection or a dangerous hazard?

por Lombardi, Carlo, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado en Asthma Res Pract (2015)

COVID-19: Unanswered questions on immune response and pathogenesis

por Maggi, Enrico, Canonica, Giorgio Walter, Moretta, Lorenzo
Publicado en J Allergy Clin Immunol (2020)

Asthma research and practice: a new journey begins

por Celedon, Juan C., Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado en Asthma Res Pract (2015)

Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

por Canonica, Giorgio Walter, Bartezaghi, Marta, Marino, Raffaele, Rigoni, Laura
Publicado en Clin Mol Allergy (2015)

Allergen immunotherapy in asthma; what is new?

por Passalacqua, Giovanni, Rogkakou, Anthi, Mincarini, Marcello, Canonica, Giorgio Walter
Publicado en Asthma Res Pract (2015)

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

por Bożek, Andrzej, Kołodziejczyk, Krzysztof, Kozłowska, Renata, Canonica, Giorgio Walter
Publicado en Clin Transl Allergy (2017)

Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair(®) In the Management of Asthma)...

por Colombo, Delia, Zagni, Emanuela, Ferri, Fabio, Canonica, Giorgio Walter
Publicado en Allergy Asthma Clin Immunol (2019)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

por Heffler, Enrico, Saccheri, Fabiana, Bartezaghi, Marta, Canonica, Giorgio Walter
Publicado en Clin Transl Allergy (2020)

Long-term effects of allergen sublingual immunotherapy

por Bozek, Andrzej, Foks, Aleksandra, Trzaska, Karolina, Canonica, Giorgio Walter
Publicado en Postepy Dermatol Alergol (2019)

Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions

por Canonica, Giorgio Walter, Arp, Jan, Keegstra, Johan René, Chrystyn, Henry
Publicado en J Aerosol Med Pulm Drug Deliv (2015)

Type 2 immunity in asthma

por Caminati, Marco, Pham, Duy Le, Bagnasco, Diego, Canonica, Giorgio Walter
Publicado en World Allergy Organ J (2018)

May We Strengthen the Human Natural Defenses with Bacterial Lysates?

por Villa, Elisa, Garelli, Valentina, Braido, Fulvio, Melioli, Giovanni, Canonica, Giorgio Walter
Publicado 2010